Hanger (HNGR) Return on Equity ROE from the second quarter 2022 to second quarter 2021 and annually, average high and low, overall ranking from Jun 30 2022 to Jun 30 2021 - CSIMarket
CSIMarket
 


Hanger inc.  (NYSE: HNGR)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare

Hanger's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Hanger in the second quarter 2022?
Hanger inc. achieved a return on average equity (ROE) of 34.41 % in its second quarter 2022, which is below Hanger's average return on equity, which stands at 3389.81%.

ROE fell compared to the first quarter 2022, despite the net income growth of % from the first quarter 2022.

Within the Healthcare Facilities industry 5 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the first quarter 2022 from 348 to 448.

What is ROE?




Return On Equity (Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
Y / Y Equity Change 95.97 % 120.44 % 116.12 % 177.15 % -
Y / Y Net Income Change -0.41 % - -12.66 % 209.86 % -67.29 %
Net Income (TTM) in Millions 37 37 42 44 30
Return On Equity (TTM) 34.41 % 40.13 % 53.68 % 69.42 % 60.52 %
HNGR's Total Ranking # 448 # 348 # 264 # 215 # 112
Equity (TTM) in Millions 125 109 110 90 64
Seq. Equity Change 15.34 % -1.47 % 23.07 % 40.11 % 29.75 %
Seq. Net Income Change - - -33.53 % 107.86 % -

Return On Equity Company Ranking
Within: No.
Industry # 6
Sector # 43
Overall # 448

Return On Equity Statistics
High Average Low
108895.89 %
3389.81 %
-2854.66 %
(Jun 30 2020)   (Mar 31 2018)





HNGR Annual Return On Equity (Dec 31 2021)
2021
(Dec 31 2020)
2020
(Dec 31 2019)
2019
(Dec 31 2018)
2018
(Dec 31 2017)
2017
Total Equity in Millions 110 51 10 -22 -28
Y / Y Equity Change 116.12 % 436.37 % - - -
Net Income in Millions 42 38 28 -1 -105
Y / Y Net Income Change 9.92 % 38.75 % - - -
Return On Equity 38.11 % 74.92 % 289.61 % - -





Annual Roe Comment
In 2021 ROE fell to 38.11 %, despite net income growth.


More Return On Equity Ratios
Healthcare Facilities Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
HNGR's' Return on Equity at Yahoo Finance
HNGR's Roe Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for HNGR's Competitors
Subscribers only: Roe for Hanger's Suppliers
Subscribers only: Return On Equity for HNGR's Customers




Companies with similar Return On Equity at Jun 30 2022, within Healthcare Sector ROE
Dynavax Technologies Corporation  93.16 %
Journey Medical Corp  85.14 %
Cartesian Therapeutics Inc   85.07 %
Abbvie Inc   84.29 %
Biomx Inc  83.21 %
Vicarious Surgical Inc  82.59 %
Maravai Lifesciences Holdings Inc   79.73 %
Sensus Healthcare Inc   74.85 %
Tenet Healthcare Corp  74.11 %
Vir Biotechnology Inc   68.86 %
Biofrontera Inc   65.87 %
Vivos Therapeutics Inc   65.69 %
Eli Lilly And Company  64.62 %
Iteos Therapeutics Inc   60.26 %
Oncotelic Therapeutics Inc   59.84 %
Vyne Therapeutics Inc   54.91 %
Siga Technologies Inc  48.79 %
REST EZ Inc.  48.50 %
Glucotrack Inc   47.72 %
Nrc Health  45.39 %
Zoetis Inc   45.24 %
Prophase Labs Inc   43.98 %
Merck and Co Inc   41.90 %
Chemed Corporation  40.26 %
Innoviva Inc   38.87 %
Cryo cell International Inc   38.23 %
Quidelortho Corp  36.94 %
Reflect Scientific Inc  36.40 %
Pfizer Inc  36.26 %
Hanger inc.  34.41 %


Date modified: 2026-09-18T13:11:05+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.